KUMEL Repository
1. Journal Papers (연구논문)
1. School of Medicine (의과대학)
Dept. of Internal Medicine (내과학)
Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18-14/KM10B)
- Affiliated Author(s)
- 박건욱
- Alternative Author(s)
- Park, Keon Uk
- Journal Title
- Breast
- ISSN
- 0960-9776
- Issued Date
- 2022
- Abstract
- We investigated the efficacy and safety of a trastuzumab biosimilar, Herzuma®, in combination with treatment of physician's choice (TPC) in patients with HER2+ metastatic breast cancer (MBC) who had failed at least two HER2 directed chemotherapies.
- Department
- Dept. of Internal Medicine (내과학)
- Publisher
- School of Medicine (의과대학)
- Type
- Article
- ISSN
- 0960-9776
- Appears in Collections:
- 1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
- 파일 목록
-
-
Download
oak-2022-0383.pdf
기타 데이터 / 2.08 MB / Unknown
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.